Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psycho-sexual therapy vs bupropion for sexual dysfunction in infertile women
IRCT2015042721955N2Phase 3Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of bupropion in female sexual dysfunction (FSD) (2 arms), sponsored by Babol University of Medical Sciences. Primary endpoint: Improvement in sexual function. Started Jan 2015; status: completed.
02
Drugs
bupropion
03
Conditions
female sexual dysfunction (FSD)
Beyond the preview
Go deeper on IRCT2015042721955N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015042721955N2.